DiponEd is an innovative healthcare bio-technology company driven by strong in-house R&D. We focus on developing next generation bio-intelligent products to address unmet healthcare needs. DiponEd offers Precision and Personalized medicine products, services, and solutions meeting global standards. The company is developing point of care biological devices for isolation of stem cells, PRP, Biologicals, Biosimilars, Neo Antigens, Cellular therapies like Mesenchymal Stem Cells, NK Cell & T cell for cancer, autoimmunity, diabetes, neurological problems, orthopaedics, infertility, cardiovascular disease, diabetes, antiaging and dermatology etc. DiponEd has also developed a range of personalized diagnostics and prognostic tests like liquid biospies, gut metagenomics, pesticide tolerance, genetic predispositions, stress scoring, 3D printed orthotics- prosthetics - modelling, drug overloads, omics of diseases etc.
Additionally, DiponEd-CRS (Contract Research Services) wing offers a R&D ecosystem with team of highly experienced and qualified scientists to provide support to many BioPharma companies. This division offers its services in the domains of integrated drug discovery of small molecules in the area of in-silico modelling, PK-PD modelling, system biology, ADME, toxicology, pre-clinical optimization, in vitro biology (Enzyme assays, Cell based assays, Ligand binding assays, GPCR, ELISA) in vivo biology etc.. DiponED also provides services in the domain of Molecular biology, immunogenicity assays, formulation development and Regulatory Assistance for Indian FDA. DiponEd also helps companies through contract manufacturing of Biologicals at it Class10,000 clean room facility.